R. LaDuane Clifton
CIK 1488774 · CFO & Treasurer · last filed 2026-01-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ZVRA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1170 CELEBRATION BLVD., #103
CELEBRATION, FL 34747
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZVRA | CFO & Treasurer | 143,515 | $10.34 | $1.48M | -$47.3K | 8 | 2026-01-07 |
| ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | CFO, Secretary & Treasurer | 9,252 | $5.81 | $53.8K | $65.9K | 37 | 2023-01-13 |
| LGL | Chief Financial Officer | 89,220 | $6.65 | $593.3K | $2.2K | 12 | 2014-03-18 |
Recent Filings · Page 3 of 6
60 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-08-24 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-24 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Buy (P) | +75 | $1.1K | EDGAR |
| 2021-05-27 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Buy (P) | +150 | $1.5K | EDGAR |
| 2020-08-26 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Buy (P) | +1,000 | $839 | EDGAR |
| 2020-08-18 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Buy (P) | +2,000 | $1.4K | EDGAR |
| 2020-06-11 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Buy (P) | +1,500 | $288 | EDGAR |
| 2020-05-26 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Buy (P) | +11,500 | $2.1K | EDGAR |
| 2020-03-25 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Buy (P) | +1,000 | $218 | EDGAR |
| 2020-03-12 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Buy (P) | +8,000 | $2.0K | EDGAR |
| 2020-02-07 | ZEVRA THERAPEUTICS, INC. (KMPH) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.